New Data Shows Limited Rise in Workplace, Roadway Cannabis Impairment

Workplace Impairment Rates Hold Steady Post-Legalization

Employer surveys across Colorado, Washington, and Oregon show workplace impairment incidents increased less than 2% in the five years following adult-use legalization. The National Safety Council's 2026 employer survey, released this week, tracked 18,000 workplaces in legal states and found that disciplinary actions for on-shift impairment rose from 1.8% of the workforce in 2020 to 1.9% in 2025. The modest uptick aligns with broader substance-use trends rather than a cannabis-specific surge.

Construction, logistics, and manufacturing employers—sectors with the strictest safety protocols—reported the most consistent enforcement. Even in those industries, managers described the challenge less as a spike in impairment and more as confusion over how to define and test for it. "We've had three incidents in four years that we could definitively tie to cannabis," said Mike Lawson, safety director at a Denver-based electrical contractor with 240 employees. "The real issue is figuring out what 'impaired' means when someone smoked yesterday."

Roadway Fatality Data Offers Mixed Signals

Traffic fatality studies show THC-positive drivers involved in fatal crashes rose 8% in legal states from 2019 to 2025, but researchers caution the data doesn't prove causation. The National Highway Traffic Safety Administration's latest report found that 14.2% of drivers killed in crashes in adult-use states tested positive for THC in 2025, up from 13.1% in 2019. THC can remain detectable in blood for days or weeks after use, making it unclear whether drivers were actively impaired at the time of the crash.

Washington State Patrol toxicologist Dr. Ellen Frost said the 5-nanogram-per-milliliter THC threshold used in many DUI cases lacks the scientific rigor of alcohol's 0.08% BAC standard. "We're seeing more THC in post-crash tests because more people use cannabis, period," she said. "That's different from proving they were high behind the wheel." Colorado and Oregon both reported flat or declining overall traffic fatality rates during the same period, complicating efforts to isolate cannabis as a causal factor.

Employers Shift from Zero-Tolerance to Impairment-Based Policies

Sixty-three percent of employers in legal states now use impairment-based assessments rather than blanket pre-employment THC screens, according to the Society for Human Resource Management. The shift reflects both legal pressure—several states now prohibit pre-hire cannabis testing for non-safety-sensitive roles—and practical recognition that metabolite tests can't distinguish last night's joint from last month's edible.

Tech firms, retail chains, and hospitality operators have led the policy overhaul. Amazon dropped cannabis screening for most warehouse roles in 2021 and reported no measurable change in workplace injury rates through 2025. Safety-sensitive industries including aviation, interstate trucking, and rail transport remain subject to federal Department of Transportation rules that mandate zero-tolerance THC testing regardless of state law.

Roadside Sobriety Tools Lag Behind Enforcement Needs

Law enforcement agencies in 11 legal states now deploy oral-fluid screening devices at DUI checkpoints, but accuracy and admissibility challenges persist. The devices, which detect THC in saliva within minutes, have shown false-positive rates as high as 18% in field trials, leading defense attorneys to challenge results in court. Michigan State Police suspended use of the Dräger DrugTest 5000 in April 2026 after a circuit court ruled the device's margin of error made results inadmissible without corroborating evidence.

California Highway Patrol continues to rely on Drug Recognition Expert officers—specially trained personnel who conduct multi-step impairment evaluations—but the program has certified only 420 officers statewide, far short of the 2,100 the agency says it needs. "We're stuck between a rock and a hard place," said CHP spokesperson Officer Linda Herrera. "The tech isn't courtroom-ready, and we don't have enough DREs to cover the state."

What Employers and Regulators Are Watching Next

Federal rescheduling of cannabis to Schedule III could force a nationwide reckoning on workplace testing standards and roadway impairment thresholds. If the DEA finalizes its proposed rule moving cannabis from Schedule I to Schedule III, employers subject to federal contracts may face conflicting guidance: state laws protecting off-duty use versus federal workplace-safety mandates. The Occupational Safety and Health Administration has signaled it will issue updated guidance on cannabis impairment by late 2026.

Researchers at the University of California San Diego are developing a breathalyzer that measures active THC rather than metabolites, with pilot testing scheduled for early 2027. If validated, the device could provide the objective standard law enforcement has lacked.

For now, the data suggests legalization's impact on workplace and roadway safety has been measurable but modest. A far cry from the worst-case scenarios that dominated the debate a decade ago. We'll be watching OSHA's guidance release and the UCSD breathalyzer trials—both could reshape impairment enforcement by mid-2027. For a deeper look at the evolving legal and policy landscape, see the CannIntel topic hub on workplace cannabis impairment.